{"url":"https://lda.senate.gov/api/v1/filings/f239dcd1-df06-46da-a134-e33fbcb2c3ff/","filing_uuid":"f239dcd1-df06-46da-a134-e33fbcb2c3ff","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2025,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/f239dcd1-df06-46da-a134-e33fbcb2c3ff/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Kelly Childress","dt_posted":"2025-10-20T12:06:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1000 Wisconsin Ave., NW","registrant_address_2":"Suite 200","registrant_different_address":false,"registrant_city":"Wasington","registrant_state":"DC","registrant_zip":"20007","registrant":{"id":400646949,"url":"https://lda.senate.gov/api/v1/registrants/400646949/","house_registrant_id":null,"name":"EAST END GROUP, LLC","description":"Consulting and government affairs.","address_1":"3 W. Irving St.","address_2":"Suite 200","address_3":null,"address_4":null,"city":"Chevy Chase","state":"MD","state_display":"Maryland","zip":"20815","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KELLY CHILDRESS LANGE","contact_telephone":"+1 202-688-1814","dt_updated":"2026-07-29T12:19:27.077010-04:00"},"client":{"id":69313,"url":"https://lda.senate.gov/api/v1/clients/69313/","client_id":69313,"name":"FRESENIUS KABI","general_description":"Development and production of essential medicines, biologics, and nutrition products.","client_government_entity":null,"client_self_select":false,"state":"IL","state_display":"Illinois","country":"US","country_display":"United States of America","ppb_state":"IL","ppb_state_display":"Illinois","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2025-09-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Funding and incentives for domestic manufacturing. Regulatory and legislative issues related to on-shoring and procurement of sterile injectable products and related medical devices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150526,"prefix":"mrs","prefix_display":"MRS.","first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CHILDRESS LANGE","suffix":null,"suffix_display":null},"covered_position":"Rep. Rogers, Health Policy Advisor; Rep. Shimkus, LA","new":false},{"lobbyist":{"id":60906,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"HAWKINS","suffix":null,"suffix_display":null},"covered_position":"Rep. Rogers, LA, Chief of Staff","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MAN","general_issue_code_display":"Manufacturing","description":"Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150526,"prefix":"mrs","prefix_display":"MRS.","first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CHILDRESS LANGE","suffix":null,"suffix_display":null},"covered_position":"Rep. Rogers, Health Policy Advisor; Rep. Shimkus, LA","new":false},{"lobbyist":{"id":60906,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"HAWKINS","suffix":null,"suffix_display":null},"covered_position":"Rep. Rogers, LA, Chief of Staff","new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Section 232 investigation into pharmaceuticals and unfair trade practices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":150526,"prefix":"mrs","prefix_display":"MRS.","first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"CHILDRESS LANGE","suffix":null,"suffix_display":null},"covered_position":"Rep. Rogers, Health Policy Advisor; Rep. Shimkus, LA","new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}